(Reuters) – The European Medicines Agency’s safety committee on Friday recommended that epilepsy drug topiramate must not be used to prevent migraine or manage body weight during pregnancy.
(Reporting by Radhika Anilkumar in Bengaluru; Editing by Savio D’Souza)
